ID   MSR3-B37
AC   CVCL_VV15
DR   Wikidata; Q95991310
RX   PubMed=10363990;
RX   PubMed=11668505;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*37:01).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VV18 ! MSR3-mel
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
RX   PubMed=10363990;
RA   Tanzarella S., Russo V., Lionello I., Dalerba P., Rigatti D.,
RA   Bordignon C., Traversari C.;
RT   "Identification of a promiscuous T-cell epitope encoded by multiple
RT   members of the MAGE family.";
RL   Cancer Res. 59:2668-2674(1999).
//
RX   PubMed=11668505; DOI=10.1002/ijc.1452;
RA   Serrano A., Tanzarella S., Lionello I., Mendez R., Traversari C.,
RA   Ruiz-Cabello Osuna F., Garrido F.;
RT   "Rexpression of HLA class I antigens and restoration of
RT   antigen-specific CTL response in melanoma cells following
RT   5-aza-2'-deoxycytidine treatment.";
RL   Int. J. Cancer 94:243-251(2001).
//